Modified Nucleoside Phosphoramidites for High-Purity Oligonucleotide Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for improved synthetic methods to produce high-purity modified oligonucleotides with diverse modifications, capable of being synthesized at higher yields and volumes to meet the demand for custom-made oligonucleotides.

Innovation Solution

Development of novel 5'-phosphoramidite nucleoside monomers represented by Formulas (I) and (II), which can be used to synthesize modified oligonucleotides, with specific structures and protecting groups, and compositions comprising these monomers with high purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional synthetic methods are used to produce modified oligonucleotides, then the synthesis can be performed with existing monomers, but the purity and yield are insufficient to meet therapeutic demand

Engineering Contradiction:
ImprovepurityVSAvoidyield
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent modifies the chemical structure of nucleoside monomers by introducing specific substituents at the 2' position (such as methoxyethyl groups) and using protected nucleobases, which changes the reaction parameters and enables higher purity and yield in oligonucleotide synthesis

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates composite monomer structures combining modified sugar moieties (with 2' substitutions) with protected nucleobases and phosphoramidite groups, resulting in monomers that simultaneously provide high purity, high yield, and diverse modification capabilities

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If existing monomers are used for oligonucleotide synthesis, then the process is straightforward, but the diversity of modifications is limited

Engineering Contradiction:
Improvediversity of modificationsVSAvoidsynthetic method complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent divides the nucleoside structure into separable functional components (sugar moiety with 2' substitution, nucleobase, and phosphoramidite group) that can be independently modified and recombined, enabling diverse oligonucleotide sequences and modifications while maintaining a systematic synthetic approach

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The modified nucleoside monomers serve multiple functions: they provide the backbone structure for oligonucleotide formation, incorporate diverse 2' substitutions for therapeutic stability, include protected nucleobases for sequence variability, and contain phosphoramidite groups for automated synthesis compatibility

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12428441B2Modified nucleoside phosphoramidites
Publication Date: 2025.09.30 JANSSEN BIOPHARMA INC
  • US12428441B2 patent drawing
  • US12428441B2 patent drawing
  • US12428441B2 patent drawing

AI summary

The present disclosure relates to compounds and compositions containing 5′-phosphoramidite nucleoside monomers, and methods of making and use.